NASHUA, N.H., July 27, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter ended June 30, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on August 10, 2022.
August 10, 2022 at 4:30 PM ET
Domestic: 888-506-0062
International: 973-528-0011
Conference ID: 718241
Webcast: https://www.webcaster4.com/Webcast/Page/2879/46166
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com
LORTON, Va., Jan. 9, 2026 /PRNewswire/ -- Avosina Healthcare Solutions ("Avosina") is notifying individuals of…
Caregiver companion, named Wellby, provides 24/7 emotional support and guidance as part of SimpleC's Connected…
REDMOND, Wash., Jan. 9, 2026 /PRNewswire/ -- Prescryptive and Ilant Health today announced a collaboration…
MIAMI, Jan. 9, 2026 /PRNewswire/ -- From January 16th to 18th, the event you need…
Investment spurs creation of Brado AI, a dedicated technology entity focused on extending provider reach…
BILLINGS, Mont., Jan. 9, 2026 /PRNewswire/ -- As the convergence of medicine and artificial intelligence…